What is the recommended initial dose of noradrenaline (norepinephrine) in septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Noradrenaline Dosing in Septic Shock

Start noradrenaline immediately when hypotension persists after initial fluid resuscitation (minimum 30 mL/kg crystalloid), titrating to achieve a mean arterial pressure (MAP) of 65 mmHg, with no specific "initial dose" recommended—rather, titrate continuously based on blood pressure response. 1, 2

Initial Administration Protocol

  • Noradrenaline is the mandatory first-choice vasopressor for septic shock with a Grade 1B recommendation from the Surviving Sepsis Campaign. 3, 1

  • Begin noradrenaline as soon as hypotension persists despite fluid resuscitation—do not delay vasopressor initiation waiting to complete all fluid administration if life-threatening hypotension exists. 1, 2

  • The target MAP is ≥65 mmHg in most patients, though higher targets may be considered in patients with chronic hypertension. 3, 1, 2

  • Require central venous access for safe administration and place an arterial catheter for continuous blood pressure monitoring as soon as practical. 3, 1, 2

Practical Dosing Considerations

While guidelines do not specify an exact "starting dose," clinical practice typically begins with low doses (e.g., 0.05-0.1 mcg/kg/min) and titrates upward. 4, 5

  • In one prospective study using a noradrenaline-based algorithm, the maximum dose required was 0.31±0.3 mcg/kg/min with 33% ICU mortality. 5

  • Consider early initiation in patients with profound hypotension, particularly when diastolic blood pressure is ≤40 mmHg or diastolic shock index (heart rate/diastolic BP) is ≥3, as these indicate severely depressed vascular tone. 6, 7

  • Early noradrenaline administration (simultaneously with fluid resuscitation) prevents prolonged hypotension, increases cardiac output, improves microcirculation, and avoids fluid overload. 4, 6, 7

Management of Refractory Hypotension

If MAP target cannot be achieved with noradrenaline alone, add vasopressin at 0.03 units/minute rather than escalating noradrenaline indefinitely. 3, 1, 2

  • Vasopressin should never be used as monotherapy—it must be added to noradrenaline. 1, 2

  • Do not exceed vasopressin doses of 0.03-0.04 units/minute except as salvage therapy, as higher doses cause cardiac, digital, and splanchnic ischemia. 1, 2

  • Noradrenaline doses ≥15 mcg/min indicate severe septic shock and warrant addition of vasopressin to spare noradrenaline requirements. 1

  • If additional support is needed, add epinephrine as a third agent (0.05-2 mcg/kg/min) rather than further escalating vasopressin. 3, 1, 2

  • Consider dobutamine (up to 20 mcg/kg/min) if persistent hypoperfusion exists despite adequate vasopressors and fluid loading, particularly with evidence of myocardial dysfunction. 3, 1, 2

Critical Pitfalls to Avoid

  • Do not use dopamine as first-line therapy—it is associated with higher mortality and more arrhythmias compared to noradrenaline, and should only be used in highly selected patients with low risk of tachyarrhythmias or absolute/relative bradycardia. 3, 1, 2

  • Strongly avoid low-dose dopamine for renal protection—this practice has no benefit and is explicitly discouraged. 1, 2

  • Do not use phenylephrine except in specific circumstances: when noradrenaline causes serious arrhythmias, when cardiac output is documented to be high with persistently low blood pressure, or as salvage therapy when all other agents have failed. 1, 2

  • Do not rely solely on blood pressure numbers—monitor markers of tissue perfusion including lactate, urine output, and mental status. 1, 2

  • Recognize that very high noradrenaline doses (>4 mcg/kg/min) indicate near-irreversible circulatory failure, though they can be administered safely when necessary with appropriate monitoring. 8

References

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinefrina en el Manejo del Shock Séptico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Research

Early norepinephrine use in septic shock.

Journal of thoracic disease, 2020

Research

Refractory septic shock: efficacy and safety of very high doses of norepinephrine.

Methods and findings in experimental and clinical pharmacology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.